HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alan C Swann Selected Research

4-aminospiroperidol

12/2015Effects of Intranasal Oxytocin on Aggressive Responding in Antisocial Personality Disorder.
6/2013Antisocial personality disorder and borderline symptoms are differentially related to impulsivity and course of illness in bipolar disorder.
1/2013Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder.
6/2012Differential relationships of impulsivity or antisocial symptoms on P50, N100, or P200 auditory sensory gating in controls and antisocial personality disorder.
11/2011Interacting mechanisms of impulsivity in bipolar disorder and antisocial personality disorder.
3/2011Criminal conviction, impulsivity, and course of illness in bipolar disorder.
1/2011Antisocial personality and bipolar disorder: interactions in impulsivity and course of illness.
1/2009A pilot study revealing impaired P50 gating in antisocial personality disorder.
9/2002Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alan C Swann Research Topics

Disease

13Bipolar Disorder (Manic Depressive Psychosis)
10/2022 - 04/2002
13Mania (Manias)
01/2015 - 04/2002
10Antisocial Personality Disorder (Antisocial Personality)
12/2015 - 09/2002
9Substance-Related Disorders (Drug Abuse)
06/2013 - 09/2002
8Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
03/2011 - 05/2003
4Treatment-Resistant Depressive Disorder
01/2022 - 09/2019
3Major Depressive Disorder (Major Depressive Disorders)
01/2023 - 04/2017
3Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2021 - 06/2003
3Borderline Personality Disorder (Personality Disorders, Borderline)
06/2013 - 03/2005
3Sleepiness
10/2006 - 12/2002
2Alcoholism (Alcohol Abuse)
07/2014 - 11/2009
2Mood Disorders (Mood Disorder)
06/2013 - 03/2011
2Schizophrenia (Dementia Praecox)
06/2013 - 03/2011
2Personality Disorders (Personality Disorder)
11/2011 - 06/2003
2Gambling (Pathological Gambling)
07/2010 - 01/2007
2Dizziness (Lightheadedness)
10/2006 - 03/2005
1Neuroinflammatory Diseases
01/2021
1Anhedonia
01/2021
1Wounds and Injuries (Trauma)
09/2019
1Psychomotor Agitation (Akathisia)
07/2014
1Obesity
03/2014
1Cocaine-Related Disorders (Cocaine Addiction)
01/2007
1Hyperkinesis
10/2006
1Nausea
03/2005
1Conduct Disorder (Conduct Disorders)
01/2004
1Depressive Disorder (Melancholia)
07/2003
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
06/2003
1Rhinitis
12/2002
1Body Weight Changes
12/2002
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2002
1Weight Gain
12/2002
1Edema (Dropsy)
12/2002
1Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder)
06/2002
1Mental Disorders (Mental Disorder)
04/2002

Drug/Important Bio-Agent (IBA)

10Valproic Acid (Depakote)FDA LinkGeneric
01/2008 - 04/2002
94-aminospiroperidolIBA
12/2015 - 09/2002
8Methylphenidate (Ritalin)FDA LinkGeneric
03/2011 - 05/2003
6KetamineFDA LinkGeneric
01/2023 - 09/2019
6LithiumIBA
01/2015 - 04/2002
5Cocaine (Cocaine HCl)IBA
07/2010 - 09/2002
3Antidepressive Agents (Antidepressants)IBA
01/2022 - 07/2003
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2021 - 01/2019
3Olanzapine (Zyprexa)FDA Link
01/2008 - 12/2002
2AZD6765IBA
11/2021 - 01/2019
2Antipsychotic Agents (Antipsychotics)IBA
01/2015 - 03/2003
2Carbamazepine (Tegretol)FDA LinkGeneric
01/2008 - 03/2005
1vasectrin II (VS II)IBA
10/2022
1Saline SolutionIBA
11/2021
1ezogabine (retigabine)IBA
01/2021
1Potassium Channels (Potassium Channel)IBA
01/2021
1KynurenineIBA
01/2021
1Glutamate Receptors (Glutamate Receptor)IBA
01/2021
1Lurasidone HydrochlorideFDA Link
04/2017
1Oxytocin (Pitocin)FDA LinkGeneric
12/2015
1Aripiprazole (Abilify)FDA Link
01/2015
1Haloperidol (Haldol)FDA LinkGeneric
01/2015
1Quetiapine Fumarate (Seroquel)FDA Link
07/2014
1EnzymesIBA
07/2014
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
03/2014
1Tiagabine (Gabitril)FDA Link
07/2012
1CatecholaminesIBA
01/2011
1Naltrexone (ReVia)FDA LinkGeneric
11/2009
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
01/2007
1Serotonin (5 Hydroxytryptamine)IBA
01/2007
1CitalopramFDA LinkGeneric
01/2007
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2007
1Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2005
1Yohimbine (Yocon)IBA
05/2005
1CholesterolIBA
03/2005
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2005
1Amphetamine (Amfetamine)FDA LinkGeneric
09/2004
14,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA
06/2002
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
04/2002

Therapy/Procedure

7Therapeutics
01/2022 - 10/2005
2Drug Therapy (Chemotherapy)
01/2007 - 04/2002
1Secondary Prevention
01/2003
1Behavior Control
04/2002